Pricing Log in Create free account

Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) vs VistaGen Therapeutics, Inc. (VTGN)

Chemomab Therapeutics Ltd. Sponsored ADR and VistaGen Therapeutics, Inc. are both Biotechnology companies. Chemomab Therapeutics Ltd. Sponsored ADR and VistaGen Therapeutics, Inc. are of similar size ($9.5M and $9.4M). Chemomab Therapeutics Ltd. Sponsored ADR has the higher net margin (0.00% vs −2,703.7%) and the lower return on invested capital (−247.4% vs 0.00%). Across the 13 metrics below, Chemomab Therapeutics Ltd. Sponsored ADR leads on 9 and VistaGen Therapeutics, Inc. on 4.

Valuation

Metric CMMB VTGN Biotechnology median
P/E n/m n/m 8.50
P/S n/m 3.44 9.71
P/B 1.17 0.35 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.21 0.64
EV/Sales n/m (5.93) 9.21
Earnings yield (63.03%) (830.00%) (33.15%)
Free cash flow yield (358.23%) (726.47%) (25.50%)

Profitability

Metric CMMB VTGN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (2,785.69%) 0.00%
Net margin 0.00% (2,703.72%) 0.00%
Free cash flow margin 0.00% (2,490.88%) 0.00%
Return on equity (82.17%) (166.46%) (56.36%)
Return on assets (70.70%) (129.22%) (48.04%)
Return on invested capital (247.40%) 0.00% 0.00%

Growth

Metric CMMB VTGN Biotechnology median
Revenue growth (TTM) — 287.15% 6.02%
EPS growth (last fiscal year) 58.14% (9.58%) 30.26%
Revenue growth, 5-year CAGR — 3.10% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMMB VTGN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.41 3.07 4.72
Net debt to EBITDA 1.09 0.63 0.96

Dividend

Metric CMMB VTGN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CMMB VTGN Biotechnology median
Market cap 9.35m 9.45m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack